Literature DB >> 8672250

Disorders of platelet function.

I Fuse1.   

Abstract

Qualitative platelet disorders are described and reviewed above. The acquired platelet function defects are very common, and sometimes result in hemorrhage, especially in association with trauma or surgery. However, the specific biochemical defect is absent, and no characterized platelet abnormalities have been recognized. On the other hand, the hereditary qualitative platelet defects are rare, but the platelet abnormalities are characteristic. The study of these patients had led to an increased understanding of the normal primary hemostatic mechanism. Recently, the molecular basis analysis of the platelet defects has been developed. This will help us understand the molecular events involved in platelet adhesion and aggregation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8672250     DOI: 10.1016/1040-8428(94)00167-7

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  4 in total

Review 1.  Our expanding view of platelet functions and its clinical implications.

Authors:  Christopher Ombrello; Robert C Block; Craig N Morrell
Journal:  J Cardiovasc Transl Res       Date:  2010-07-27       Impact factor: 4.132

2.  Liver Transplantation in a Patient with Acquired Dysfibrinogenemia Who Presented with Subdural Hematoma: A Case Report.

Authors:  Şencan Acar; Gökhan Güngör; Murat Dayangaç; Reyhan Diz-Küçükkaya; Yaman Tokat; Murat Akyıldız
Journal:  Turk J Haematol       Date:  2016-06-07       Impact factor: 1.831

3.  4-Аminopyridine sequesters intracellular Ca2+ which triggers exocytosis in excitable and non-excitable cells.

Authors:  Ludmila A Kasatkina
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

4.  Prevalence of disease and relationships between laboratory phenotype and bleeding severity in platelet primary secretion defects.

Authors:  Luca A Lotta; Alberto Maino; Giacomo Tuana; Raffaella Rossio; Anna Lecchi; Andrea Artoni; Flora Peyvandi
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.